Skincare company Medik8 has introduced its Niacinamide Peptides serum.
Available through aesthetic distributor Healthxchange, the product aims to visibly refine the pores, reduce blemishes and enhance skin cell renewal. Medik8 shares that the serum features 10% niacinamide, crystalide peptide, hyaluronic acid and n-acetyl glucosamine.
In a clinical study conducted over four weeks on 30 participants, the serum produced a 35% reduction in visible blemishes and 26% reduction in visible pore size in four weeks. In a separate four-week clinical trial using 83 participants, 100% showed a healthier skin barrier within one week, and 94% agreed the serum was gentle on the skin.
Simone Shoffman, education and clinical director at Healthxchange, commented, “Medik8’s Niacinamide Peptides launch represents exactly the kind of results-driven innovations we’re proud to bring to our professional partners. We’re delighted to support its rollout across the professional channel and anticipate strong enthusiasm from practitioners looking to elevate their patients routines.”